Insider Notice: IDXX 407 Shares to be Sold via Morgan Stanley on NASDAQ

Rhea-AI Filing Summary

Form 144 notice for IDEXX Laboratories (IDXX) reports a proposed sale of 407 common shares through Morgan Stanley Smith Barney LLC on NASDAQ with an aggregate market value of $264,533.53. The filing lists the company's outstanding shares as 80,004,694, so the proposed sale represents approximately 0.00051% of outstanding stock. The acquisition history provided shows the shares originated from multiple Employee Stock Purchase Plan purchases and a Restricted Stock grant, with acquisition dates ranging from 06/30/2021 through 03/29/2024. The filer certifies they are not aware of undisclosed material adverse information and uses Morgan Stanley as the executing broker. The proposed approximate sale date is 08/12/2025.

Positive

• Complete disclosure of broker, exchange, proposed sale date, and aggregate market value
• Acquisition history provided showing Employee Stock Purchase Plan and Restricted Stock origins
• Filer certification that no undisclosed material adverse information is known

Negative

• None.

Insights

Securities Analyst

TL;DR: Small insider sale notice: 407 shares valued at $264,533.53—negligible versus 80,004,694 outstanding shares.

The Form 144 documents a planned sale under Rule 144 for 407 common shares using Morgan Stanley as broker with an aggregate value of $264,533.53. Given the stated 80,004,694 shares outstanding, the sale equals roughly 0.00051% of the float, indicating the transaction is immaterial to company capital structure. The filing includes a clear acquisition record showing multiple Employee Stock Purchase Plan purchases and a Restricted Stock grant, and the filer affirms no undisclosed material adverse information. From a market-impact perspective, the notice signals compliance rather than a material shift in ownership.

Corporate Governance Expert

TL;DR: Compliance-focused filing: disclosure of provenance and broker details; sale size is trivial relative to outstanding shares.

The Form 144 provides the necessary disclosure elements: broker name (Morgan Stanley Smith Barney LLC), exchange (NASDAQ), proposed sale date (08/12/2025), and a detailed acquisition history (ESPP and Restricted Stock entries). The filer also makes the standard certification regarding material non-public information. These items demonstrate adherence to disclosure rules for an insider sale; nothing in the filing raises governance or compliance concerns based on the information presented.

FAQ

What does the IDEXX (IDXX) Form 144 report?

The filing reports a proposed sale of 407 common shares valued at $264,533.53 to be executed through Morgan Stanley Smith Barney LLC on NASDAQ.

When is the proposed sale date on the IDXX Form 144?

The approximate date of sale listed in the notice is 08/12/2025.

How significant is the proposed sale relative to IDEXX's outstanding shares?

The filing lists 80,004,694 shares outstanding; the proposed sale of 407 shares represents about 0.00051% of that total.

What is the origin of the shares being sold in the IDXX Form 144?

The acquisition table shows most shares came from multiple Employee Stock Purchase Plan purchases and one Restricted Stock grant, with acquisition dates between 06/30/2021 and 03/29/2024.

Who is the executing broker named in the Form 144 for IDXX?

The broker named is Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, 8th Floor, New York, NY 10004.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/12/2025 - 06:32 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002005385
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IDEXX LABORATORIES, INC.
SEC File Number	000-19271
Address of Issuer	One IDEXX Drive Westbrook MAINE 04092
Phone	207-556-0300
Name of Person for Whose Account the Securities are To Be Sold	MICHAEL G ERICKSON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	407	264533.53	80004694	08/12/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/31/2023	Employee Stock Purchase Plan	ISSUER			15	03/31/2023	Cash
Common	06/30/2023	Employee Stock Purchase Plan	ISSUER			12	06/30/2023	Cash
Common	09/30/2021	Employee Stock Purchase Plan	ISSUER			9	09/30/2021	Cash
Common	12/31/2021	Employee Stock Purchase Plan	ISSUER			10	12/31/2021	Cash
Common	02/14/2024	Restricted Stock	ISSUER			318	02/14/2024	Not Applicable
Common	03/31/2022	Employee Stock Purchase Plan	ISSUER			9	03/31/2022	Cash
Common	03/29/2024	Employee Stock Purchase Plan	ISSUER			11	03/29/2024	Cash
Common	06/30/2021	Employee Stock Purchase Plan	ISSUER			9	06/30/2021	Cash
Common	12/29/2023	Employee Stock Purchase Plan	ISSUER			14	12/29/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/S/ Michael G Erickson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)